How have FONR shares performed in 2024?

FONAR's stock was trading at $19.56 at the beginning of 2024. Since then, FONR shares have decreased by 14.1% and is now trading at $16.81. View the best growth stocks for 2024 here .

Are investors shorting FONAR?

FONAR saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 8,500 shares, a decrease of 14.1% from the March 15th total of 9,900 shares. Based on an average daily volume of 19,000 shares, the short-interest ratio is currently 0.4 days. Currently, 0.1% of the shares of the company are sold short. View FONAR's Short Interest .

When is FONAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our FONR earnings forecast .

How were FONAR's earnings last quarter?

FONAR Co. (NASDAQ:FONR) announced its quarterly earnings results on Wednesday, February, 14th. The medical equipment provider reported $0.54 earnings per share for the quarter. The medical equipment provider had revenue of $25.39 million for the quarter. FONAR had a net margin of 12.63% and a trailing twelve-month return on equity of 8.47%.

What other stocks do shareholders of FONAR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FONAR investors own include Gilead Sciences (GILD) , Amarin (AMRN) , CRISPR Therapeutics (CRSP) , Exelixis (EXEL) , Pfizer (PFE) , Bausch Health Companies (BHC) , Incyte (INCY) , Jazz Pharmaceuticals (JAZZ) , Lannett (LCI) and Madrigal Pharmaceuticals (MDGL) .

Who are FONAR's major shareholders?

FONAR's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Denali Advisors LLC (0.25%). Insiders that own company stock include Luciano B Bonanni and Timothy Raymond Damadian. View institutional ownership trends .

How do I buy shares of FONAR?

Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:FONR

FONAR (FONR) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free FONR Stock Alerts

$16.81

-0.02 (-0.12%)

(As of 04/19/2024 ET)

Compare

Today's Range: $16.80
▼
$17.04
50-Day Range: $16.52
▼
$23.24
52-Week Range: $12.13
▼
$24.05

Volume: 5,681 shs
Average Volume: 18,956 shs
Market Capitalization: $106.37 million

P/E Ratio: 9.14
Dividend Yield: N/A
Price Target: N/A

Get FONAR alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About FONAR Stock (NASDAQ:FONR)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

FONR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FONR Stock News Headlines

April 13, 2024 | americanbankingnews.com

FONAR (NASDAQ:FONR) vs. Lonza Group (OTCMKTS:LZAGY) Head to Head Survey

April 10, 2024 | americanbankingnews.com

FONAR (NASDAQ:FONR) Share Price Crosses Above 200-Day Moving Average of $18.78

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

April 10, 2024 | seekingalpha.com

FONAR: Recent Selloff Seems Unjustified As EV/EBITDA Approaches 4x

March 16, 2024 | finance.yahoo.com

FONAR's (NASDAQ:FONR) investors will be pleased with their respectable 36% return over the last year

February 16, 2024 | wsj.com

Fonar Corp.

February 15, 2024 | finance.yahoo.com

FONAR Corporation's (NASDAQ:FONR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

February 14, 2024 | sfgate.com

Fonar: Fiscal Q2 Earnings Snapshot

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

February 14, 2024 | finanznachrichten.de

Fonar Corporation: Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024

February 14, 2024 | finance.yahoo.com

Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024

February 1, 2024 | morningstar.com

Fonar Corp FONR

January 1, 2024 | finance.yahoo.com

FONAR (NASDAQ:FONR) Is Reinvesting At Lower Rates Of Return

December 29, 2023 | stocknews.com

2024 Strategies: Buy or Hold for 3 Medical Stocks?

December 28, 2023 | stocknews.com

Holiday Outlook: 3 Medical Stocks to Consider Buying

November 30, 2023 | finance.yahoo.com

Is Now The Time To Put FONAR (NASDAQ:FONR) On Your Watchlist?

November 17, 2023 | stocknews.com

Henry Schein (HSIC) Q3 Earnings Analysis: A Medical Stock to Watch?

November 16, 2023 | finance.yahoo.com

Individual investors who hold 51% of FONAR Corporation (NASDAQ:FONR) gained 23%, institutions profited as well

November 15, 2023 | finance.yahoo.com

Fonar Corp (FONR) Reports Substantial Growth in Q1 Fiscal 2024 Earnings

November 14, 2023 | msn.com

Fonar GAAP EPS of $0.59, revenue of $25.84M

November 8, 2023 | finance.yahoo.com

Fonar Announces Distributor Agreement with AIRS Medical, Leader in AI-Powered MRI Technology

October 8, 2023 | finance.yahoo.com

FONAR (NASDAQ:FONR) shareholders have endured a 36% loss from investing in the stock five years ago

September 28, 2023 | finanznachrichten.de

Fonar Corporation: FONAR Announces Financial Results for Fiscal 2023

September 4, 2023 | finance.yahoo.com

Pleasing Signs As A Number Of Insiders Buy FONAR Stock

August 3, 2023 | msn.com

Back Into FONAR Corporation

July 15, 2023 | finance.yahoo.com

Some Investors May Be Worried About FONAR's (NASDAQ:FONR) Returns On Capital

June 26, 2023 | thestreet.com

Fonar Shares Drop on Volume Spike

See More Headlines

Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/14/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:FONR
CUSIP: N/A
CIK: 355019
Web: www.fonar.com
Phone: (631) 694-2929
Fax: 631-753-5150
Employees: 561
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $1.84
Trailing P/E Ratio: 9.14
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $9.38 million
Net Margins: 12.63%
Pretax Margin: 19.92%
Return on Equity: 8.47%
Return on Assets: 6.45%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.35
Quick Ratio: 9.15

Sales & Book Value

Annual Sales: $102.42 million
Price / Sales: 1.04
Cash Flow: $2.83 per share
Price / Cash Flow: 5.94
Book Value: $23.07 per share
Price / Book: 0.73

Miscellaneous

Outstanding Shares: 6,328,000
Free Float: 5,785,000
Market Cap: $106.37 million
Optionable: Not Optionable
Beta: 1.12

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Timothy R. Damadian M.D. (Age 60)
Chairman, President, CEO & Treasurer
Comp: $152.9k
Mr. Luciano B. Bonanni (Age 69)
COO, Executive VP & Acting Principal Financial Officer
Comp: $449.22k
Ms. Claudette J. V. Chan (Age 86)
Secretary & Director
Comp: $58.88k

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

FONR Stock Analysis - Frequently Asked Questions

How have FONR shares performed in 2024?: FONAR's stock was trading at $19.56 at the beginning of 2024. Since then, FONR shares have decreased by 14.1% and is now trading at $16.81.
View the best growth stocks for 2024 here.
Are investors shorting FONAR?: FONAR saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 8,500 shares, a decrease of 14.1% from the March 15th total of 9,900 shares. Based on an average daily volume of 19,000 shares, the short-interest ratio is currently 0.4 days. Currently, 0.1% of the shares of the company are sold short.
View FONAR's Short Interest.
When is FONAR's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our FONR earnings forecast.
How were FONAR's earnings last quarter?: FONAR Co. (NASDAQ:FONR) announced its quarterly earnings results on Wednesday, February, 14th. The medical equipment provider reported $0.54 earnings per share for the quarter. The medical equipment provider had revenue of $25.39 million for the quarter. FONAR had a net margin of 12.63% and a trailing twelve-month return on equity of 8.47%.

What other stocks do shareholders of FONAR own?: Based on aggregate information from My MarketBeat watchlists, some companies that other FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC), Incyte (INCY), Jazz Pharmaceuticals (JAZZ), Lannett (LCI) and Madrigal Pharmaceuticals (MDGL).
Who are FONAR's major shareholders?: FONAR's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Denali Advisors LLC (0.25%). Insiders that own company stock include Luciano B Bonanni and Timothy Raymond Damadian.
View institutional ownership trends.
How do I buy shares of FONAR?: Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FONR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

FONAR (FONR) Stock Price, News & Analysis

About FONAR Stock (NASDAQ:FONR)

FONR Stock Price History

FONR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

FONR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info